MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bcmd.2026.103035

Медицинская библиотека · Blood cells, molecules & diseases · 2026

Characterisation of clinical, hematological and molecular variability in individuals with sickle β-thalassemia.

Gawit Kalpita, Jaganathasamy Nagaraj, Umare Vinod, Dadheech Sneha, Thaker Pallavi, Shinde Nikhil, Jawade Aruna, Dhumane Umesh, Dewalkar Swati, Moon Amol, Meregu Naga Murlidhar, Bayaskar Sagar, Khobragade Aniruddha, Jain Dipty, Nadkarni Anita, Mukherjee Malay, Kedar Prabhakar, Madkaikar Manisha

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Sickle β-thalassemia (Sβ-thal) is a compound hemoglobinopathy resulting in marked clinical and hematologic heterogeneity. Despite a substantial disease burden in India, large-cohort data integrating molecular, hematologic, and clinical characteristics remain limited, particularly from regions with evolving screening programs.

OBJECTIVES

The study aimed to characterise the clinical, hematological, and molecular features of a large cohort of individuals diagnosed with sickle β-thal.

METHODS

A retrospective analysis of 206 molecularly confirmed Sβ-thal patients enrolled (2016 and 2024) at ICMR-CRMCH, Chandrapur. The demographic, clinical, and hematological parameters were analysed, including HPLC, along with molecular characterisation of β-globin mutations, α-globin gene deletions, and XmnI polymorphism using polymerase chain reaction-based methods.

RESULTS

The mean age was 16.5 ± 13.2 years; 52.9% were female, and 77.7% were non-tribal. On molecular analysis, IVS I-5 (G > C) was the most common variant (98.0%), followed by Codon 15 (G > A) (1.5%) and Codon 8/9 (+G) (0.5%). The genotype αα/αα was predominant in the cohort (90.9%), and 86% were heterozygous for the Xmn1 polymorphism (+/-). HPLC longitudinal follow-up of children (newborn screening to 36 months) revealed that HbA2 (3.0-4.0%) stabilized after 18-24 months. In the clinical history of hospitalisation (58.5%), blood transfusions (51.8%), acute chest syndrome (27.4%), and splenomegaly (8.6%) were observed.

CONCLUSION

These findings delineate the genotypic and phenotypic spectrum of Sβ-thal and underscore the need for cautious interpretation of HbA₂ in early childhood diagnosis and follow-up.

Для цитирования: Gawit Kalpita, Jaganathasamy Nagaraj, Umare Vinod, Dadheech Sneha, Thaker Pallavi, Shinde Nikhil, Jawade Aruna, Dhumane Umesh, Dewalkar Swati, Moon Amol, Meregu Naga Murlidhar, Bayaskar Sagar, Khobragade Aniruddha, Jain Dipty, Nadkarni Anita, Mukherjee Malay, Kedar Prabhakar, Madkaikar Manisha. Characterisation of clinical, hematological and molecular variability in individuals with sickle β-thalassemia.. Blood cells, molecules & diseases. 2026. DOI: 10.1016/j.bcmd.2026.103035.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.